ES2029805T3 - Procedimiento para preparar un producto que contiene amantadina y selegilina en asociacion sinergica. - Google Patents

Procedimiento para preparar un producto que contiene amantadina y selegilina en asociacion sinergica.

Info

Publication number
ES2029805T3
ES2029805T3 ES198787104818T ES87104818T ES2029805T3 ES 2029805 T3 ES2029805 T3 ES 2029805T3 ES 198787104818 T ES198787104818 T ES 198787104818T ES 87104818 T ES87104818 T ES 87104818T ES 2029805 T3 ES2029805 T3 ES 2029805T3
Authority
ES
Spain
Prior art keywords
selegiline
preparing
procedure
product containing
containing amantadine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787104818T
Other languages
English (en)
Inventor
Dirk Dr. Reischig
Helmut Dr. Hettche
Wolfgang Dr. Brade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Application granted granted Critical
Publication of ES2029805T3 publication Critical patent/ES2029805T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

MEDICAMENTOS CON ACCION SINERGICA, QUE CONTIENEN UNA COMBINACION DE AMANTADINA Y SELEGILINA.
ES198787104818T 1986-04-16 1987-04-01 Procedimiento para preparar un producto que contiene amantadina y selegilina en asociacion sinergica. Expired - Lifetime ES2029805T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3612702 1986-04-16

Publications (1)

Publication Number Publication Date
ES2029805T3 true ES2029805T3 (es) 1992-10-01

Family

ID=6298731

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787104818T Expired - Lifetime ES2029805T3 (es) 1986-04-16 1987-04-01 Procedimiento para preparar un producto que contiene amantadina y selegilina en asociacion sinergica.

Country Status (19)

Country Link
US (1) US4812481A (es)
EP (1) EP0241809B1 (es)
JP (1) JPS62249923A (es)
AT (1) ATE55245T1 (es)
AU (1) AU598533B2 (es)
CA (1) CA1298200C (es)
DD (1) DD259352A5 (es)
DE (1) DE3764144D1 (es)
DK (1) DK168514B1 (es)
ES (1) ES2029805T3 (es)
FI (1) FI871668A (es)
GR (1) GR3000707T3 (es)
HU (1) HU197840B (es)
IE (1) IE60245B1 (es)
IL (1) IL82216A0 (es)
NO (1) NO871581L (es)
PL (1) PL265152A1 (es)
PT (1) PT84684B (es)
ZA (1) ZA872690B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
EP0536277A1 (en) * 1990-06-25 1993-04-14 The Du Pont Merck Pharmaceutical Company Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5175002A (en) * 1991-10-02 1992-12-29 Du Pont Merck Pharmaceutical Company Amantadine hydrochloride syspension with enhanced dissolution characteristics for use in soft gelatin capsules
EP0612348B1 (en) 1991-11-04 2003-04-23 Genetics Institute, LLC Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
US6348208B1 (en) * 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
JPH11504944A (ja) * 1995-11-06 1999-05-11 サマーセット・ファーマシューティカルズ・インコーポレイテッド セレギリンの舌下およびバッカル投与
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
GB9715082D0 (en) * 1997-07-17 1997-09-24 Scherer Ltd R P Treatment of attention deficit hyperactivity disorder and narcolepsy
DK1063981T3 (da) 1998-03-16 2002-10-14 Somerset Pharmaceuticals Inc Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader
AU1359801A (en) * 1999-11-05 2001-06-06 Vela Pharmaceuticals Inc. Methods and compositions for treating reward deficiency syndrome
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
EP1487427A4 (en) * 2002-03-04 2006-01-18 Somerset Pharmaceuticals Inc METHODS FOR PREVENTING AND TREATING PERIPHERAL NEUROPATHY BY ADMINISTERING DESMETHYLSELEGILINE
CA2523567A1 (en) * 2003-04-25 2004-11-11 Indevus Pharmaceuticals, Inc. Method for promoting uninterrupted sleep by administration of trospium chloride
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
PL1675608T3 (pl) 2003-09-12 2007-11-30 Wyeth Corp Stałe fosforanowo wapniowe pałeczki do wstrzyknięć dla dostarczania białek osteogennych
AU2005209310B2 (en) * 2004-01-29 2011-01-06 Neuromolecular, Inc. Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPH-inhibitor for the treatment of central nervous system-related conditions
AU2005215775B2 (en) * 2004-02-13 2011-02-03 Neuromolecular, Inc. Combination of a NMDA receptor antagonist and an anti-depressive drug MAO-inhibitor or a GADPH-inhibitor for the treatment of psychiatric conditions
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US8058291B2 (en) * 2005-04-06 2011-11-15 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of CNS-related conditions
CA2588296A1 (en) 2004-11-24 2006-06-01 Neuromolecular Pharmaceuticals, Inc. Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
WO2006091544A2 (en) * 2005-02-22 2006-08-31 Northwestern University Methods and compositions for modulating calcium channels
HUE050758T2 (hu) 2005-04-05 2021-01-28 Univ Yale Glutamátmoduláló szerek mentális rendellenességek kezelésére
PL2303330T5 (pl) 2008-06-06 2021-10-25 Pharma Two B Ltd. Kompozycje farmaceutyczne do leczenia choroby Parkinsona
MX365650B (es) 2009-12-02 2019-06-10 Adamas Pharmaceuticals Inc Composiciones de amantadina y metodos para su uso.
WO2014204933A1 (en) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE314077C (es) *
AT314077B (de) * 1972-01-07 1974-03-25 Hurka Wilhelm Verfahren zur Herstellung eines neuen, gegen den Parkinsonismus wirksamen Kombinationspräparates
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity

Also Published As

Publication number Publication date
NO871581L (no) 1987-10-19
DE3764144D1 (de) 1990-09-13
EP0241809B1 (de) 1990-08-08
US4812481A (en) 1989-03-14
DD259352A5 (de) 1988-08-24
HU197840B (en) 1989-06-28
IE870973L (en) 1987-10-16
AU598533B2 (en) 1990-06-28
CA1298200C (en) 1992-03-31
PT84684B (pt) 1989-12-29
PL265152A1 (en) 1988-07-07
GR3000707T3 (en) 1991-10-10
HUT43789A (en) 1987-12-28
ZA872690B (en) 1988-03-30
FI871668A (fi) 1987-10-17
DK197787A (da) 1987-10-17
FI871668A0 (fi) 1987-04-15
DK197787D0 (da) 1987-04-15
DK168514B1 (da) 1994-04-11
EP0241809A1 (de) 1987-10-21
AU7154187A (en) 1987-10-29
IE60245B1 (en) 1994-06-15
NO871581D0 (no) 1987-04-14
PT84684A (de) 1987-05-01
JPS62249923A (ja) 1987-10-30
IL82216A0 (en) 1987-10-30
ATE55245T1 (de) 1990-08-15

Similar Documents

Publication Publication Date Title
ES2029805T3 (es) Procedimiento para preparar un producto que contiene amantadina y selegilina en asociacion sinergica.
ES2104973T3 (es) Metodo para producir un recipiente para productos alimentarios.
ATE91688T1 (de) Phospholipidische komplexe aus vitis viniferaextrakten, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
MX15464A (es) Bis(hidroximetil)ciclobutil purinas y pirimidinas y procedimiento para su preparacion.
ES551119A0 (es) Procedimiento para preparar un agente analgesicamente activo a base de 2-amino-3-carboetoxiamino-6-(4-fluorobencilamino)-piridina y por lo menos un agente antiflogistico no esteroidal
AR226865A1 (es) Procedimiento para preparar un producto de carne embutida que tiene sabor acido y el producto resultante
DE3583887D1 (de) Ausruestung fuer die behandlung der osteoporose.
MX9101034A (es) Mezclas y composiciones que contienen fenotiazinas y proceso para su preparacion
MX9100613A (es) Corticoide-17-alquilcarbonatos sustituidos en posicion 17,procedimientos para su preparacion,y medicamentos que los contienen
MX5999E (es) Procedimiento para la preparacion de composiciones farmaceuticas que contienen fumarato de benciclano y ciclodextrina
MX14310A (es) Procedimiento para la preparacion de nuevos agentes antiarritmicos, producto obtenido y preparacion farmaceutica que lo incluye.
GR3002917T3 (en) Synergistic mixture of azelastine and theophylline or of azelastine and beta-mimetics
MX9304185A (es) Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina.
PT91084A (pt) Processo para a producao de composicoes contendo agentes apaladantes para a intoducao em produtos alimentares sem gordura e de produtos alimentares que os contem
ES2071081T3 (es) Liposomas fosfolipidicos que contienen principios activos y un procedimiento para su obtencion.
MX14512A (es) Composicion fotopolimerizable y articulo que comprende la composicion.
AR228255A1 (es) Procedimiento para la produccion de una preparacion sinergistica que tiene una actividad analgesica y miotonolitica mejorada
ES2045008T3 (es) Procedimiento para la obtencion de preparados en combinacion antidepresivos.
ES541944A0 (es) Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables
ES2022501B3 (es) Procedimiento para preparar un aducto de lactato calcico y glicerol, y su empleo.
USD226823S (en) Impeller for mixing liquids or the like
SE9002447L (sv) Foer hudlotioner, hudkraemer o.l. avsett koncentrat
ATA22989A (de) Behandlungsliege, insbesondere massageliege
AR247329A1 (es) Aderezos de carne y pescado para sopas.
IT1248867B (it) Composizione farmaceutica per il trattamento della ascite aviaria